Editorial – Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: the importance of disease heterogeneity
M. Infante, C. Ricordi Diabetes Research Institute (DRI), University of Miami Miller School of Medicine, Miami, FL, USA. marcoinfante.md@gmail.com
Free PDF Download
![Creative Commons License](https://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
M. Infante, C. Ricordi
Editorial – Moving forward on the pathway of targeted immunotherapies for type 1 diabetes: the importance of disease heterogeneity
Eur Rev Med Pharmacol Sci
Year: 2019
Vol. 23 - N. 19
Pages: 8702-8704
DOI: 10.26355/eurrev_201910_19188